1035TiP A phase I/Ib study of MPT-0118 as monotherapy and in combination with pembrolizumab in subjects with advanced or metastatic solid tumors

Sommerhalder, D., Lim, E. A., Pande, A., & Keller, P. (2021). 1035TiP A phase I/Ib study of MPT-0118 as monotherapy and in combination with pembrolizumab in subjects with advanced or metastatic solid tumors. Annals of Oncology, 32, S866. https://doi.org/10.1016/j.annonc.2021.08.1419
Authors:
David Sommerhalder
Elgene Lim
A. U. Pande
Peter M. Keller
Affiliated Authors:
Elgene Lim
Columbia Affiliation:
Subjects:
Therapeutic Antibodies: Development, Engineering, and Applications (OpenAlex Topic)
HER2 Signaling in Breast Cancer Treatment (OpenAlex Topic)
Development and Applications of Radiopharmaceuticals (OpenAlex Topic)
elink
Publication Type:
Article
Unique ID:
10.1016/j.annonc.2021.08.1419
DOI:
10.1016/j.annonc.2021.08.1419
Journal:
Annals of Oncology
Publication Date:
Data Source:
OpenAlex
Source Link:
View OpenAlex Record

Record Created: